Posted: Monday, April 22, 2024
Shaji K. Kumar, MD, of the Mayo Clinic Comprehensive Cancer Center, discusses changes to the treatment landscape for patients with multiple myeloma. He details the latest thinking on managing smoldering disease and the role of lenalidomide, induction with a quadruplet regimen followed by autologous transplant and maintenance, appropriate treatment for relapsed disease, and T-cell therapies.